Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
2000 1
2001 1
2008 1
2009 2
2010 1
2011 3
2012 2
2013 1
2014 4
2015 1
2016 2
2017 2
2018 8
2019 3
2020 3
2021 3
2022 4
2023 5
2024 8
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, Haight PJ, Tubbs C, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Chambers LM. Riedinger CJ, et al. Gynecol Oncol. 2024 Apr;183:78-84. doi: 10.1016/j.ygyno.2024.03.020. Epub 2024 Mar 29. Gynecol Oncol. 2024. Retraction in: Gynecol Oncol. 2024 Apr;183:R1. doi: 10.1016/j.ygyno.2024.04.024. PMID: 38554477 Free article. Retracted.
Is all chronic kidney disease created equal?
Lane BR, Demirjian S, Derweesh IH, Riedinger CB, Fergany AF, Campbell SC. Lane BR, et al. Among authors: riedinger cb. Curr Opin Urol. 2014 Mar;24(2):127-34. doi: 10.1097/MOU.0000000000000029. Curr Opin Urol. 2014. PMID: 24451089 Review.
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State University.
Levine MD, Wagner VM, Riedinger CJ, Khadraoui W, Haight PJ, Morton M, Barrington DA, Calo CA, Castaneda AV, Lightfoot M, Chalif J, Gonzalez A, Cohn DE. Levine MD, et al. Among authors: riedinger cj. Gynecol Oncol Rep. 2024 Jan 29;52:101327. doi: 10.1016/j.gore.2024.101327. eCollection 2024 Apr. Gynecol Oncol Rep. 2024. PMID: 38390623 Free PMC article. Review.
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein Interaction.
Chessari G, Hardcastle IR, Ahn JS, Anil B, Anscombe E, Bawn RH, Bevan LD, Blackburn TJ, Buck I, Cano C, Carbain B, Castro J, Cons B, Cully SJ, Endicott JA, Fazal L, Golding BT, Griffin RJ, Haggerty K, Harnor SJ, Hearn K, Hobson S, Holvey RS, Howard S, Jennings CE, Johnson CN, Lunec J, Miller DC, Newell DR, Noble MEM, Reeks J, Revill CH, Riedinger C, St Denis JD, Tamanini E, Thomas H, Thompson NT, Vinković M, Wedge SR, Williams PA, Wilsher NE, Zhang B, Zhao Y. Chessari G, et al. Among authors: riedinger c. J Med Chem. 2021 Apr 8;64(7):4071-4088. doi: 10.1021/acs.jmedchem.0c02188. Epub 2021 Mar 24. J Med Chem. 2021. PMID: 33761253
53 results